Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Pharmather Hldgs Ltd (PHRM.CN)

Pharmather Hldgs Ltd (PHRM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PharmaTher Introduces PatchPrint(TM) With Provisional Patent Filing and Commercialization Strategy for Microneedle Patches Newsfile - Thu Mar 26, 7:27AM CDT

Leveraging its PharmaPatch™ experience, the Company is introducing PatchPrint™ to support existing microneedle patch programs and expand into on-demand personalized patch solutions, including peptide...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)
PharmaTher Expands PharmaPatch Delivery Platform into Therapeutic Peptides for the U.S. Market Newsfile - Tue Mar 3, 7:08AM CST

Toronto, Ontario--(Newsfile Corp. - March 3, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the therapeutic...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)
PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success Newsfile - Mon Feb 2, 8:40AM CST

Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) (the "Company" or "PharmaTher"), a specialty pharmaceutical company, today announced a new strategic...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)
PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs Newsfile - Wed Jan 14, 7:04AM CST

Toronto, Ontario--(Newsfile Corp. - January 14, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)
PharmaTher CEO Publishes Letter to Shareholders Newsfile - Fri Jan 2, 7:04AM CST

Toronto, Ontario--(Newsfile Corp. - January 2, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher") today announced that CEO Fabio Chianelli has published a letter...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)
PharmaTher Closes Sale of Ketamine ANDA, Sharpening Focus on Long-Acting Injectable Ketamine Franchise Newsfile - Tue Dec 2, 2025

Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the therapeutic...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)
PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program Newsfile - Mon Nov 17, 2025

Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)
Upcoming Meeting Dates - November 3, 2025 Newsfile - Sun Nov 2, 2025

Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - The following is a list of Upcoming Meeting Dates for Reporting Issuers in Canada. The data is supplied by Issuing Companies through the service...

KEC.TO : 24.73 (+0.12%)
SUP.VN : 2.590 (+3.60%)
FMT.VN : 10.500 (-0.10%)
BARU.VN : 0.040 (unch)
SPN.VN : 0.055 (unch)
ESBL.VN : 0.145 (-6.45%)
GRDM.VN : 0.125 (+4.17%)
VGD.VN : 0.175 (-2.78%)
ESAU.CN : 0.5400 (-1.82%)
NTE.VN : 0.065 (+8.33%)
PRR.CN : 0.0750 (unch)
BY.CN : 0.0450 (unch)
PharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale Newsfile - Fri Oct 17, 2025

Toronto, Ontario--(Newsfile Corp. - October 17, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the pharmaceutical...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)
PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson's Disease Newsfile - Thu Oct 16, 2025

Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoingToronto, Ontario--(Newsfile Corp. - October 16, 2025) - PharmaTher...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0470 (-6.00%)

Barchart Exclusives

Sysco Just Announced a $29.1 Billion Acquisition and Wall Street Is Nervous. Can a 3% Dividend Sweeten the Deal? Barchart - Thu Apr 2, 6:30PM CDT
The Jetro deal strategically pushes Sysco into a faster‑growing, higher‑margin channel, but the new debt, jumping leverage, share dilution, and negative S&P outlook explain why SYY stock just had its worst day since 2020. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.